Blossom Mak

ORCID

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Venues

Therapeutic advances in medical oncology

Prostate cancer and prostatic diseases

Cancers

JCO clinical cancer informatics

University of New South Wales (BSC)

This page only lists publications with an associated author ORCID identifier.

Education History

University of New South Wales

Australia

BSC

Publications

Tahlia Scheinberg, Blossom Mak, Lisa Butler, Luke Selth, Lisa G Horvath
Targeting lipid metabolism in metastatic prostate cancer. Therapeutic advances in medical oncology 15 (2023)
Shikai Fang, Shandian Zhe, Hui Ming Lin, Arun A Azad, Heidi Fettke, Edmond M Kwan, Lisa Horvath, Blossom Mak, Tiantian Zheng, Pan Du, Shidong Jia, Robert M Kirby, Manish Kohli
Multi-Omic Integration of Blood-Based Tumor-Associated Genomic and Lipidomic Profiles Using Machine Learning Models in Metastatic Prostate Cancer. JCO clinical cancer informatics 7 (2023)
Tahlia Scheinberg, Blossom Mak, Lisa Butler, Luke Selth, Lisa G Horvath
Targeting lipid metabolism in metastatic prostate cancer. Therapeutic advances in medical oncology 15 (2023)
Tahlia Scheinberg, Hui Ming Lin, Michael Fitzpatrick, Arun A Azad, Paul Bonnitcha, Amy Davies, Gillian Ziona Heller, Kevin Huynh, Blossom Mak, Kate Mahon, David Sullivan, Peter J Meikle, Lisa G Horvath
PCPro: a clinically accessible, circulating lipid biomarker signature for poor-prognosis metastatic prostate cancer. Prostate cancer and prostatic diseases (2023)
Ciara Conduit, Blossom Mak, Wenjia Qu, Juliana Di Lulio, Ronan Burder, Matthias Bressel, Thomas Cusick, Haryana M Dhillon, Richard De Abreu Lourenço, Craig Underhill, Javier Torres, Megan Crumbaker, Florian Honeyball, Anthony Linton, Ray Allen, Ian D Davis, Susan J Clark, Lisa G Horvath, Kate L Mahon
GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel versus standard-of-care docetaxel in metastatic castration-resistant prostate cancer (clinical trial protocol). Therapeutic advances in medical oncology 14 (2022)
Blossom Mak, Hui Ming Lin, Thy Duong, Kate L Mahon, Anthony M Joshua, Martin R Stockler, Howard Gurney, Francis Parnis, Alison Zhang, Tahlia Scheinberg, Gary Wittert, Lisa M Butler, David Sullivan, Andrew J Hoy, Peter J Meikle, Lisa G Horvath
Modulation of Plasma Lipidomic Profiles in Metastatic Castration-Resistant Prostate Cancer by Simvastatin. Cancers 14 (19) (2022)

Blossom Mak.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Blossom Mak